The unopposed alpha-stimulation phenomenon: What is the role of beta-blockers?

John R Richards, Howard E. McKinney, Bernard Silke

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

The experimental phenomenon of unopposed α-stimulation (UAS) is essentially the increase in systemic vascular resistance, peripheral blood pressure, and/or coronary arterial vasoconstriction after administration of a β-blocker. The explanations for the putative physiological mechanisms behind this phenomenon seem straightforward and plausible. However, upon further investigation, the autonomic nervous system regulation of blood pressure, heart rate, and coronary epicardial and microvascular blood flow is based on a complex relationship among the sympathetic α- and β-adrenergic system, parasympathetic acetylcholinergic system, endothelium-dependent coronary vasodilation, pressure-dependent autoregulation, and, most importantly, metabolic demand. These increases in blood pressure and coronary arterial vasoconstriction are usually mild and insignificant, but rarely may be profound, with potential for deleterious outcome to the experimental subject or patient. In this chapter, we review the known and theoretical pathophysiology behind UAS.

Original languageEnglish (US)
Title of host publicationBeta-Blockers
Subtitle of host publicationPhysiological, Pharmacological and Therapeutic Implications
PublisherNova Science Publishers, Inc.
Pages167-229
Number of pages63
ISBN (Electronic)9781536133127
ISBN (Print)9781536133110
StatePublished - Jan 1 2018

Fingerprint

Vasoconstriction
Blood Pressure
Autonomic Nervous System
Vasodilation
Vascular Resistance
Adrenergic Agents
Endothelium
Arterial Pressure
Homeostasis
Heart Rate
Pressure

ASJC Scopus subject areas

  • Medicine(all)
  • Pharmacology, Toxicology and Pharmaceutics(all)

Cite this

Richards, J. R., McKinney, H. E., & Silke, B. (2018). The unopposed alpha-stimulation phenomenon: What is the role of beta-blockers? In Beta-Blockers: Physiological, Pharmacological and Therapeutic Implications (pp. 167-229). Nova Science Publishers, Inc..

The unopposed alpha-stimulation phenomenon : What is the role of beta-blockers? / Richards, John R; McKinney, Howard E.; Silke, Bernard.

Beta-Blockers: Physiological, Pharmacological and Therapeutic Implications. Nova Science Publishers, Inc., 2018. p. 167-229.

Research output: Chapter in Book/Report/Conference proceedingChapter

Richards, JR, McKinney, HE & Silke, B 2018, The unopposed alpha-stimulation phenomenon: What is the role of beta-blockers? in Beta-Blockers: Physiological, Pharmacological and Therapeutic Implications. Nova Science Publishers, Inc., pp. 167-229.
Richards JR, McKinney HE, Silke B. The unopposed alpha-stimulation phenomenon: What is the role of beta-blockers? In Beta-Blockers: Physiological, Pharmacological and Therapeutic Implications. Nova Science Publishers, Inc. 2018. p. 167-229
Richards, John R ; McKinney, Howard E. ; Silke, Bernard. / The unopposed alpha-stimulation phenomenon : What is the role of beta-blockers?. Beta-Blockers: Physiological, Pharmacological and Therapeutic Implications. Nova Science Publishers, Inc., 2018. pp. 167-229
@inbook{f4b63b6525cf4785a28e16adf3cb5e5a,
title = "The unopposed alpha-stimulation phenomenon: What is the role of beta-blockers?",
abstract = "The experimental phenomenon of unopposed α-stimulation (UAS) is essentially the increase in systemic vascular resistance, peripheral blood pressure, and/or coronary arterial vasoconstriction after administration of a β-blocker. The explanations for the putative physiological mechanisms behind this phenomenon seem straightforward and plausible. However, upon further investigation, the autonomic nervous system regulation of blood pressure, heart rate, and coronary epicardial and microvascular blood flow is based on a complex relationship among the sympathetic α- and β-adrenergic system, parasympathetic acetylcholinergic system, endothelium-dependent coronary vasodilation, pressure-dependent autoregulation, and, most importantly, metabolic demand. These increases in blood pressure and coronary arterial vasoconstriction are usually mild and insignificant, but rarely may be profound, with potential for deleterious outcome to the experimental subject or patient. In this chapter, we review the known and theoretical pathophysiology behind UAS.",
author = "Richards, {John R} and McKinney, {Howard E.} and Bernard Silke",
year = "2018",
month = "1",
day = "1",
language = "English (US)",
isbn = "9781536133110",
pages = "167--229",
booktitle = "Beta-Blockers",
publisher = "Nova Science Publishers, Inc.",

}

TY - CHAP

T1 - The unopposed alpha-stimulation phenomenon

T2 - What is the role of beta-blockers?

AU - Richards, John R

AU - McKinney, Howard E.

AU - Silke, Bernard

PY - 2018/1/1

Y1 - 2018/1/1

N2 - The experimental phenomenon of unopposed α-stimulation (UAS) is essentially the increase in systemic vascular resistance, peripheral blood pressure, and/or coronary arterial vasoconstriction after administration of a β-blocker. The explanations for the putative physiological mechanisms behind this phenomenon seem straightforward and plausible. However, upon further investigation, the autonomic nervous system regulation of blood pressure, heart rate, and coronary epicardial and microvascular blood flow is based on a complex relationship among the sympathetic α- and β-adrenergic system, parasympathetic acetylcholinergic system, endothelium-dependent coronary vasodilation, pressure-dependent autoregulation, and, most importantly, metabolic demand. These increases in blood pressure and coronary arterial vasoconstriction are usually mild and insignificant, but rarely may be profound, with potential for deleterious outcome to the experimental subject or patient. In this chapter, we review the known and theoretical pathophysiology behind UAS.

AB - The experimental phenomenon of unopposed α-stimulation (UAS) is essentially the increase in systemic vascular resistance, peripheral blood pressure, and/or coronary arterial vasoconstriction after administration of a β-blocker. The explanations for the putative physiological mechanisms behind this phenomenon seem straightforward and plausible. However, upon further investigation, the autonomic nervous system regulation of blood pressure, heart rate, and coronary epicardial and microvascular blood flow is based on a complex relationship among the sympathetic α- and β-adrenergic system, parasympathetic acetylcholinergic system, endothelium-dependent coronary vasodilation, pressure-dependent autoregulation, and, most importantly, metabolic demand. These increases in blood pressure and coronary arterial vasoconstriction are usually mild and insignificant, but rarely may be profound, with potential for deleterious outcome to the experimental subject or patient. In this chapter, we review the known and theoretical pathophysiology behind UAS.

UR - http://www.scopus.com/inward/record.url?scp=85048452320&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85048452320&partnerID=8YFLogxK

M3 - Chapter

AN - SCOPUS:85048452320

SN - 9781536133110

SP - 167

EP - 229

BT - Beta-Blockers

PB - Nova Science Publishers, Inc.

ER -